Welcome to our new website. We have rebranded from Atnahs to Pharmanovia — read more

27th January 2020

Atnahs Acquires Rights to Established Hypertension Medicines

Basildon / Cambridge (UK), 27 January 2020 – Atnahs, a Triton Fund V portfolio company, has signed...

More information
8th August 2019

Triton Completes Acquisition of a Majority Stake in Atnahs

Frankfurt (Germany), Basildon (United Kingdom), August 8, 2019 – Funds advised by Triton have successfully completed...

More information
14th December 2018

Atnahs Acquires Famvir®

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of Famvir® from...

More information
1st December 2018

Atnahs Opens New Branch in the United Arab Emirates (UAE)

Dubai, UAE. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the opening of a new...

More information
28th February 2018

Atnahs Acquires Remaining Stake in Pharmanovia A/S in Denmark

Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of the remaining share capital...

More information
1st November 2017

Atnahs Launches Traxidot® (Tranexamic Acid) in the Netherlands

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the launch of Traxidot® (Tranexamic...

More information
1st October 2017

Atnahs Opens New Branch in India

Baroda, India. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the opening of a new...

More information
7th July 2017

Atnahs Launches Clobazam in UK, Iloprost in Portugal and Dropizol® in Denmark

Atnahs Pharma UK Limited (“Atnahs”), and its partners Pharmanovia A/S (“Pharmanovia”) and Pharmamentum ApS (“Pharmamentum”), are...

More information
3rd July 2017

Atnahs Acquires Rights for Bonviva® and Bondronat®

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of worldwide rights...

More information